SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: art slott who wrote (370)1/16/2000 7:34:00 PM
From: Jim Mac  Read Replies (2) of 413
 
I doubt it.

From what I've read at Dillon Read, the PTO is very likely to give VISX an amended patent which supercedes the '388, and will give VISX the same intellectual property monopoly as it had before.

If VISX was in trouble, then why did Lasik Vision decide to make 100-laser purchase deal with VISX? Because VISX's patent position is sound and Nidek will likely lose in CA civil court with the patent ammo VISX could not use during the ITC proceeding. Plus, all users of Nidek lasers will be sued and will likely lose, either by owing treble damages, or costly litigation in defense of themselves.

I think Raging Bull is buying into the ill-informed conventional wisdom which has contributed to VISX tanking recently.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News